SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 

 

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

November 10, 2016

Date of report (Date of earliest event reported)

 

 

 

BIOLIFE SOLUTIONS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware	001-36362	94-3076866
(State or Other Jurisdiction of Incorporation)	(Commission File No.)	(IRS Employer Identification No.)

 

3303 Monte Villa Parkway, Bothell, WA 98021

(Address of principal executive offices, including zip code)

 

(425) 402-1400

(Registrant’s telephone number, including area code) 

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 2.02.   Results of Operations and Financial Condition.

 

On November 10, 2016, BioLife Solutions, Inc. (the “Company”) issued a press release announcing financial results of the Company for the third quarter ended September 30, 2016. A copy of the press release is furnished as Exhibit 99.1 to this current report on Form 8-K.

 

 

Item 9.01.   Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.		Description
99.1		Press release dated November 10, 2016

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	BIOLIFE SOLUTIONS, INC.
Dated: November 10, 2016	By:	/s/ Roderick de Greef
		Roderick de Greef
		Chief Financial Officer

 

 

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Press release dated November 10, 2016